期刊文献+

国产与进口奥氮平治疗60例精神分裂症的疗效比较 被引量:2

Domestic and imported Olanzapine treat schizophrenia curative effect comparison
下载PDF
导出
摘要 目的:探讨国产奥氮平治疗精神分裂症的疗效及不良反应。方法:60例精神分裂症患者分为两组:国产奥氮平组30例,男性19例,女性11例,年龄(37±8)岁,给予国产奥氮平口服。进口奥氮平组30例,男性20例,女性10例,年龄(36±8)岁,给予进口奥氮平口服。两组开始剂量均为10 mg/d,以后视病情调整,平均(15±2.5)mg/d,分2次口服,共治疗6 w。采用阳性症状与阴性症状量表(PANSS)评定临床疗效,同时采用不良反应症状量表(TESS)评定不良反应。结果:国产奥氮平组的有效率达87%,与进口奥氮平组(90%)比较无显著差异(P>0.05)。国产奥氮平组的不良反应为嗜睡、体重增加,血糖、胆固醇及三酰甘油升高的发生率与进口奥氮平比较无显著差异(P>0.05)。结论:国产奥氮平是一种安全、有效的治疗精神分裂症的药物。 Objectlve:To explore domestic Olanzapine treat schizophrenia curative effect and adverse reaction. Methods:Sixty patients with schizophrenia patients are divided into two groups : domestic Olanzapine group of 30 cases with men 19 cases and women 11 cases, age (37 ± 8) years old, give domestic Olanzapine oral. Import Olanzapine group of 30 cases with men 20 cases, women 10 cases, age (36 ±8) years old, give the imported Olanzapine oral. Two groups start dose for 10 mg/d,and depend on the disease to ad- just dose, an average of( 15 ± 2.5 ) mg/d and points 2 times oral and treatment for 6 weeks. With the Positive And Negative Symptoms Scale (PANSS) assesses clinical curative effect, at the same time use the Treatment Emergent Side -Effect Scale(TESS) evaluates adverse reactions. Results: Domestic Olanzapine group the effective rate is 87%, and there are no significant differences with imported Olanzapine group (90%). Domestic Olanzapine group of adverse reactions are drowsiness, gain weight. Blood sugar, cholesterol and triacylglycerol increasing compared to imported Olanzapine are no significant differences. Conclusions: Domestic Olanzapine is a safe and effective drug in the treatment for schizophrenia.
出处 《中国民康医学》 2011年第23期2902-2903,共2页 Medical Journal of Chinese People’s Health
关键词 抗精神病药 国产奥氮平 精神分裂症 Antipsychotic Drug Domestic Olanzapine Schizophrenia
  • 相关文献

参考文献4

  • 1KAY SR, SANDY KR. Interpretation of the positive-negative distinction[ A]. KAY SR. Positive and negative syndroms in schizophrenia : assessment and research [ M ]. New York : Brunner/mazel, 1991:194 -213.
  • 2李华杰,吴爱勤.奥氮平的药理学及临床应用[J].临床精神医学杂志,2001,11(2):114-117. 被引量:107
  • 3Carlson CD, Cavazzoni PA, Berg PH, et al. Analysis of olanzapine treatschizophrenia's acute EPS and Compare with placebo, haloperidol, risperdone and olanzapine [ J ]. J Clin Psychiatry,2003,64:896-906.
  • 4孙中国,潘惟华,王春芝.奥氮平治疗难治性精神分裂症临床观察[J].临床精神医学杂志,2003,13(1):24-25. 被引量:16

二级参考文献22

  • 1[1]Bymaster FP,Calligaro DO,Falcone JF,et al.Radioreceptor binding profile of the atypical antipsychotic olanzapine.Neuropsychopharmacology ,1996,14:87
  • 2[2]Kapur S,Zipursky RB,Remington G,et al.Clinical and theor etical implications of 5-HT2 and D2 receptor occupancy of clozapine,risperi dole,and olanzapine in schizophreia.Am J Psychiatry,1999,156:286
  • 3[3]Arnt J,Skarsfeldt J.Do noval antipsychotics have similar pharmacological characteristics?a review of the evidence.Neuropsychopharmacolog y,1998,16:63
  • 4[4]Bymaster FP.In vivo and in vitro biochemistry of olanzap ine.J Clin Psychiatry,1997,58(suppl 10):28
  • 5[5]Tandon R,Milner K,Jibson MD.Antipsychotics from theory t o practice:integrating clinical and basic data.J Clin Psychiatry,1999,60(suppl 8 ):21
  • 6[6]Beasley CM,Tollefson GD,Tran PV,et al.The efficacy of ol anzapine:the summary of global,multicentral clinical trials.J Clin Psychiatry,19 97,58(suppl 10):7
  • 7[7]Sanger TM,Lieberman JA,Tohen M,et al.Olanzapine versus h aloperidol treatment in first-episode psychosis.Am J Psychiatry,1999,156:79
  • 8[8]Tran PV,Hamilton SH,Runtz AJ,et al.Double-blind compari son of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 9[9]Brier A,Hamilton SH.Comparative efficacy olanzapine and haloperidol for patients with treatmen-resistant schizophrenia.Biol Psychiatry,45:403
  • 10[10] Henderson DC,Nasrallah RA,Goff DC,et al.Switching from clozapin e to olanzapine in treatment-resistant schizophrenia:safety clinical effecacy,a nd predictors of response.J Clin Psychiatry,1998,59:585

共引文献113

同被引文献22

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部